Thromboelastography‐guided therapy improves patient blood management and certain clinical outcomes in elective cardiac and liver surgery and emergency resuscitation: A systematic review and analysis

Start Date: ,

End Date: ,

Thromboelastography‐guided therapy improves patient blood management and certain clinical outcomes in elective cardiac and liver surgery and emergency resuscitation: A systematic review and analysis

Abstract

Essentials

TEG‐guided therapy has been shown to be valuable in a number of surgical settings.
This systematic review and analysis specifically evaluated the effects of TEG‐guided therapy.
TEG‐guided therapy can improve blood product utilization and enhance resource management.
Use of TEG improved key patient outcomes, including bleed rate, length of stay and mortality.

Background

Thromboelastography (TEG 5000 and 6s Thrombelastograph Hemostasis Analyzer; Haemonetics) is a point‐of‐care system designed to monitor and analyze the entire coagulation process in real time. TEG‐guided therapy has been shown to be valuable in a variety of surgical settings.

Objective

To conduct an analysis of published clinical trials to evaluate the effects of TEG‐guided transfusion for the management of perioperative bleeding on patient outcomes.

Back to All Events